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Abstract 
Gene therapy is expected to open a new strategy for the treatment of refractory 
vascular diseases, so the development of appropriate gene vectors for vascular lesions is 
needed. To realize this requirement with a non-viral approach, cyclo(RGDfK) peptide 
(cRGD) was introduced to block copolymer, poly(ethylene glycol)-block-polycation 
carrying ethylenediamine units (PEG-PAsp(DET)). cRGD recognizes αvβ3 and αvβ5 
integrins, which are abundantly expressed in vascular lesions. cRGD-conjugated 
PEG-PAsp(DET) (cRGD-PEG-PAsp(DET)) formed polyplex micelles through 
complexation with plasmid DNA (pDNA), and the cRGD-PEG-PAsp(DET) micelles 
achieved significantly more efficient gene expression and cellular uptake as compared 
with PEG-PAsp(DET) micelles in endothelial cells and vascular smooth muscle cells. 
Intracellular tracking of pDNA showed that cRGD-PEG-PAsp(DET) micelles were 
internalized via caveolae-mediated endocytosis, which is associated with a pathway 
avoiding lysosomal degradation, and that PEG-PAsp(DET) micelles were transported to 
acidic endosomes and lysosomes via clathrin-mediated endocytosis. Further, in vivo 
evaluation in rat carotid artery with a neointimal lesion revealed that 
cRGD-PEG-PAsp(DET) micelles realized sustained gene expression, while 
PEG-PAsp(DET) micelles facilitated rapid but transient gene expression. These findings 
suggest that introduction of cRGD to polyplex micelles might create novel and useful 
functions for gene transfer and contribute to the establishment of efficient gene therapy 
for vascular diseases. 
 
Keywords: gene delivery; vascular lesion; neointimal hyperplasia; polyplex micelle; 
cyclo(RGDfK) peptide 
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Introduction 
Therapeutic application of gene delivery techniques is expected to open a new 
strategy for the treatment of refractory vascular disease, and a variety of methods have 
been proposed for delivering therapeutic genes to vascular wall cells.1,2 In these 
methods, viral vectors have been mostly utilized as the gene carrier, since gene transfer 
efficiency with viral vectors is generally superior to that of other non-viral methods. 
However, there are some limitations in the clinical application of viral vectors, the most 
critical of which might be the problem of safety due to antigenicity and oncogenicity.3,4 
These issues of viral vectors have impelled the development of non-viral vectors with 
safety and reasonable efficiency of gene transfer.5,6 Polyplex and lipoplex systems, in 
which plasmid DNA (pDNA) forms a polyion complex with cationic polymers and 
cationic lipids, respectively, have been widely studied as conventional non-viral 
vectors.7-10 It is known that polyplex and lipoplex potentially achieve desirable 
efficiency of gene transfer in vitro. However, positive charges on these vectors 
potentially induce cytotoxicity and nonspecific aggregation with plasma proteins, 
indicating that in vivo administration of these vectors might be considerably 
restricted.11,12 
Polyplex micelles were developed to resolve these restrictions of non-viral vectors. 
They were constructed from newly synthesized block copolymer characterized by 
tandem alignment of a hydrophilic poly(ethylene glycol) (PEG) segment and a 
polycationic segment.13-15 Then, a proper mixture of the block copolymer and pDNA 
potently forms stable polyplex micelles that possess a unique core-shell structure of a 
hydrophilic shell layer surrounding a polyplex core.16,17 Because of the hydrophilic 
property of the PEG shell, the polyplex micelle minimizes nonspecific interactions with 
4 
 
various bio-components, realizing high biocompatibility and stability in vivo.18-20 In 
previous studies, we also designed PEG-block-polycation carrying ethylenediamine 
units in the side chain (PEG-PAsp(DET)), and reported that polyplex micelles with 
PEG-PAsp(DET) accomplished appreciable gene transfer efficiency with low 
cytotoxicity.20,21 After internalization of PEG-PAsp(DET) micelles into the intracellular 
compartment by endocytosis, the ethylenediamine units are expected to promote 
translocation of the polyplex micelles toward the cytoplasm due to endosomal 
membrane destabilization, resulting in improvement of gene transfer efficiency.22,23 
Furthermore, to increase cellular uptake of polyplex micelles, we recently attempted to 
introduce appropriate ligands into the surface of the polyplex micelles.24-26 The installed 
ligands potently enhanced uptake into the targeted cells by inducing receptor-mediated 
endocytosis, while polyplex micelles without ligands were taken up only through 
adsorptive or fluid-phase endocytosis. 
In the present study, cyclo(RGDfK) peptide (cRGD) was introduced to the PEG 
terminal of PEG-PAsp(DET) in order to function as a specific ligand on the surface of 
the polyplex micelle (Fig. 1). cRGD peptide selectively recognizes αvβ3 and αvβ5 
integrins,27 and previous studies showed that αvβ3 and αvβ5 are abundantly expressed on 
endothelial cells and smooth muscle cells in vascular lesions.28-30 PEG-PAsp(DET) 
micelles installed with cRGD (cRGD-PEG-PAsp(DET) micelles) were applied to 
endothelial cells and vascular smooth muscle cells in vitro and also to rat carotid artery 
with neointimal hyperplasia, and the efficacy of gene transfer was evaluated as 
compared with that of ligand-free PEG-PAsp(DET) micelles. 
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Results 
Expression of αvβ3 and αvβ5 integrins on HUVEC and VSMC 
To evaluate the expression of αvβ3 and αvβ5 ingtegrins on vascular wall cells, flow 
cytometric analysis of human umbilical vein endothelial cells (HUVEC) and human 
vascular smooth muscle cells (VSMC) was carried out using FITC-labeled antibodies 
against αvβ3 and αvβ5. Flow cytometric analysis revealed considerable expression of 
αvβ3 and αvβ5 on HUVEC and VSMC as compared with control (Fig. 2a, b). 
 
In vitro gene transfer to HUVEC and VSMC 
The expression plasmid vector containing the luciferase gene was complexed with 
cRGD-PEG-PAsp(DET) at various N/P ratios, and applied to HUVEC or VSMC in vitro. 
Here, N/P ratio refers to the unit molar ratio of amino groups in the polymer to 
phosphate groups in the pDNA. Gene expression was assessed by measuring luciferase 
activity 24 hours later, and polyplex micelles with PEG-PAsp(DET) were utilized in the 
same manner as control. In gene transfer to HUVEC, luciferase activity after treatment 
with cRGD-PEG-PAsp(DET) micelles was significantly higher than that with 
PEG-PAsp(DET) micelles at N/P ratios of, 5 and 10 (Fig. 3a). At N/P ratios of 2, 20 and 
30, no remarkable difference in luciferase activity was detected between 
cRGD-PEG-PAsp(DET) micelles and PEG-PAsp(DET) micelles, though the activity 
was appreciably high at N/P ratios of 20 and 30. In gene transfer to VSMC, 
cRGD-PEG-PAsp(DET) micelles showed significantly higher luciferase activity at N/P 
ratios of 4 and 5, as compared with PEG-PAsp(DET) micelles, while there was no 
difference in activity between the two types of micelles at N/P ratios of 2, 10 and 20 
(Fig. 3b). 
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Cellular uptake of polyplex micelles 
To assess uptake of cRGD-PEG-PAsp(DET) micelles into vascular cells in vitro, 
Cy5-labeled pDNA (Cy5-pDNA) was complexed with cRGD-PEG-PAsp(DET) at N/P 
ratio of 5, and administered to HUVEC or VSMC in vitro. Intensity of Cy5 incorporated 
into these cells was analyzed by flow cytometry at 0.5, 1, 3 and 6 hours after 
administration. PEG-PAsp(DET) micelles containing Cy5-pDNA were used as control. 
In both HUVEC and VSMC, the intracellular intensity of Cy5 after transfer with 
cRGD-PEG-PAsp(DET) micelles were significantly higher than that with 
PEG-PAsp(DET) micelles at all time points except 6 hours in VSMC (Fig. 4a, b). 
 
Intracellular distribution of polyplex micelles 
Other sets of cultured HUVEC and VSMC were also treated with 
cRGD-PEG-PAsp(DET) micelles or PEG-PAsp(DET) micelles containing Cy5-pDNA, 
and the intracellular distribution of Cy5-pDNA (red) was evaluated at 6 and 24 hours by 
confocal laser scanning microscopy (CLSM). Simultaneously, HUVEC and VSMC 
were stained with LysoTracker Green (green) to identify acidic endosomes and 
lysozomes, or cholera toxin subunit B (CT-B) Alexa Fluor 488 (green) for lipid rafts and 
caveosomes, and colocalization with incorporated Cy5-pDNA was quantified. In 
HUVEC, intracellular Cy5-pDNA after transfer with PEG-PAsp(DET) micelles 
considerably colocalized with LysoTracker Green as compared with that with 
cRGD-PEG-PAsp(DET) micelles at 6 and 24 hours after treatment (Fig. 5b). On the 
contrary, Cy5-pDNA after transfer with cRGD-PEG-PAsp(DET) micelles markedly 
colocalized with CT-B as compared with that with PEG-PAsp(DET) micelles (Fig. 5a). 
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These findings were statistically confirmed by quantitative analyses using colocalization 
ratio (Fig. 5c, d). The same experiments using VSMC showed similar results. 
Cy5-pDNA transferred with cRGD-PEG-PAsp(DET) micelles tended to colocalize with 
intracellular CT-B, and that with PEG-PAsp(DET) micelles tended to associate with 
LysoTracker Green at both 6 and 24 hours after application of micelles, which were 
confirmed by statistical analyses (Fig. 5e-h). 
 
Gene transfer to neointimal lesion induced in rat carotid artery 
Rat carotid artery was injured with a balloon catheter, which induced neointimal 
hyperplasia by 21 days after injury. Expression pDNA fused with luciferase gene was 
complexed with cRGD-PEG-PAsp(DET) at N/P ratio of 5, and polyplex micelles were 
administered into the carotid artery with neointima. The carotid arteries were sampled at 
1, 2, 3 and 4 days after treatment, and luciferase activity of the carotids was measured to 
evaluate gene expression in the arteries. PEG-PAsp(DET) micelles complexed with 
luciferase pDNA (N/P ratio = 5) were applied in the same manner as control. In the 
carotid arteries subjected to cRGD-PEG-PAsp(DET) micelles, maximum activity of 
luciferase was observed at 2 days after application of micelles, and activity on day 3 and 
4 was similar to that on day 1 (Fig. 6a). On the contrary, in the arteries treated with 
PEG-PAsp(DET) micelles, luciferase activity showed a maximum value on day 1, 
though only low level activity was detected on day 3 and 4. Statistical analyses showed 
that the day 1 activity of carotid samples treated with PEG-PAsp(DET) micelles was 
significantly higher than that with cRGD-PEG-PAsp(DET) micelles. However, on day 3 
and 4, arterial samples after treatment with cRGD-PEG-PAsp(DET) micelles showed 
significantly high luciferase activity as compared with those after application of 
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PEG-PAsp(DET) micelles. There was no difference in values on day 2 between the two 
groups. 
pDNA was also complexed with cRGD-PEG-PAsp(DET) or PEG-PAsp(DET) at 
N/P ratio of 20. The micelles were applied into carotid arteries with neointima in the 
same manner. In the carotid arteries subjected to cRGD-PEG-PAsp(DET) micelles and 
also those with PEG-PAsp(DET), luciferase measurement showed markedly low 
activity on day 2 and also day 3, which was significantly lower than that after 
application of micelles with N/P ratio of 5 (Fig. 6b, c). 
 
In vivo uptake of polyplex micelles 
To evaluate in vivo uptake of polyplex micelles in the rat carotid artery with 
neointima, Cy3-labeled pDNA was complexed with cRGD-PEG-PAsp(DET) or 
PEG-PAsp(DET) at N/P ratio of 5, and the micelles were administered into the arteries 
(Fig. 7). At 1 day after application of micelles, the carotid arteries were excised, and 
cross sections were analyzed with a fluorescence microscope. In carotid arteries 
subjected to cRGD-PEG-PAsp(DET) micelles, considerable diffuse fluorescence of Cy3 
was observed in all of the neointimal layer, while scarce fluorescence was detected in 
arteries treated with PEG-PAsp(DET) micelles (Fig. 7a, b). Cy3 intensity in the 
neointima was quantified as fluorescence intensity index, and the index after treatment 
with cRGD-PEG-PAsp(DET) micelles was significantly higher than that with 
PEG-PAsp(DET) micelles (Fig. 7c). 
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Discussion 
In the present study, cRGD peptide was introduced to the surface of polyplex 
micelles with PEG-PAsp(DET) as a specific ligand for αvβ3 and αvβ5, and its gene 
transfer efficacy to vascular wall cells and lesion-induced artery was analyzed in 
comparison with that of ligand-free PEG-PAsp(DET) micelles. PEG-PAsp(DET) 
micelles complexed with pDNA tightly pack the DNA into a dense shell layer of 
hydrophilic PEG, assuring high stability and biocompatibility in vivo.16,17 Further, after 
cellular uptake by endocytosis, the ethylenediamine units of the polycation are potently 
protonated in the endosome and considered to promote desirable translocation toward 
the cytoplasm due to endosomal membrane destabilization.22,23 Our previous study 
indeed showed that administration of PEG-PAsp(DET) micelles into rabbit carotid 
artery accomplished appreciable gene transfer to the artery without occlusion by 
thrombus formation.20 In contrast, the same study revealed that polyplex made from 
polyethyleneimine markedly caused thrombus occlusion after intra-arterial application, 
indicating that positively charged polyplex potentially underwent aggregation with 
plasma proteins and blood cells. Since thrombus formation possibly interferes with the 
process of gene transfer and further impairs vascular functions, it appears necessary for 
gene vectors for the treatment of vascular diseases to possess non-thrombogenic 
properties, like PEG-PAsp(DET) micelles. 
It is known that αvβ3 and αvβ5 integrins are expressed on various vascular cells 
such as endothelial cells, smooth muscle cells and macrophages, and that they play an 
important role in atherogenesis and formation of other vascular lesions, which was a 
rational basis for selection of cRGD peptide as a ligand of the gene vector for vascular 
lesions.28,31-35 In the present study, HUVEC and VSMC were used for in vitro study. We 
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were initially concerned about the possibility that integrins expressed on HUVEC and 
VSMC markedly differed from those on endothelial cells and smooth muscle cells in 
vascular lesions in vivo, since neither of these cells was harvested from the diseased 
artery. However, flow cytometry revealed obvious expression of αvβ3 and αvβ5 on 
HUVEC and VSMC, indicating that these cells were appropriate for in vitro evaluation 
of the micelles. 
In vitro study using the luciferase gene showed that gene expression after transfer 
with cRGD-PEG-PAsp(DET) micelles was significantly higher than that with 
PEG-PAsp(DET) micelles in both HUVEC and VSMC at low N/P ratios. This finding 
clearly demonstrated that introduction of cRGD potentially improved the gene 
expression efficiency of the micelles at low N/P ratios. We previously carried out gene 
transfer experiments using HeLa cells, which abundantly express αvβ3 and αvβ5, and 
reported similar improvement of gene expression after delivery with cRGD-fused 
polyplex micelles, while no improvement was detected in 293 cells expressing neither 
αvβ3 nor αvβ5.36 One possible mechanism to explain the improvement might be that 
association of cRGD ligands with αvβ3 and αvβ5 integrins efficiently enhanced cellular 
uptake of polyplex micelles through receptor-mediated endocytosis. Indeed, in both 
HUVEC and VSMC, cellular uptake of Cy5-pDNA after treatment with 
cRGD-PEG-PAsp(DET) micelles (N/P = 5) was significantly higher than that with 
PEG-PAsp(DET) micelles (N/P = 5) at 0.5, 1 and 3 hours after treatment. A previous 
study using HeLa cells also showed that simultaneous administration of free cRGD 
peptides considerably reduced the improvement of gene transfer with cRGD-fused 
polyplex micelles, suggesting a contribution of receptor-mediated uptake due to cRGD 
ligands.37 Another possible mechanism for the improved gene expression with 
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cRGD-PEG-PAsp(DET) micelles might be that cRGD ligands modulated intracellular 
trafficking after uptake of the polyplex micelles. In CLSM analyses of HUVEC and 
VSMC, pDNA transferred with cRGD-PEG-PAsp(DET) micelles tended to co-localize 
with lipid rafts and caveosomes, and pDNA after transfer with PEG-PAsp(DET) 
micelles tended to associate with acidic endosomes and lysosomes. Grosse et al. 
evaluated the cellular uptake of particles that were not installed with any ligands, and 
showed that the process of cellular uptake depended upon particle size; particles with 
>200 nm diameter were internalized by macropinocytosis, particles with 100-200 nm 
diameter by clathrin-mediated endocytosis, and particles <100 nm diameter by 
caveolae-mediated endocytosis.38 The average diameter of cRGD-PEG-PAsp(DET) and 
PEG-PAsp(DET) micelles was around 100 nm, with a moderate distribution. Since 
PEG-PAsp(DET) micelles were particles without ligands, a main process in cellular 
uptake of PEG-PAsp(DET) micelles was then suspected to be clathrin-mediated 
endocytosis, and the principle components of the endocytic pathway are endosomes and 
lysozomes, supporting the CLSM findings on PEG-PAsp(DET) micelles. Meanwhile, 
previous studies showed that expression of αvβ3 integrins promoted cellular uptake via 
caveolae-mediated endocytosis, and that αvβ5 expression facilitated clathrin-mediated 
endocytosis.39-41 Since the binding affinity of cRGD with αvβ3 is 10 times stronger than 
that with αvβ5, it might be reasonable that caveolae-mediated endocytosis was a 
dominant process in cellular uptake of cRGD-PEG-PAsp(DET) micelles.42 In contrast to 
clathrin-mediated endocytosis, the internalization pathway via caveolae-mediated 
endocytosis is known to bypass degradative organelles and not to be associated with a 
decrease in pH. Therefore, it is possible that cRGD-PEG-PAsp(DET) micelles enabled 
avoidance of enzymatic degradation after internalization via caveolae-mediated 
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endocytosis, resulting in enhanced gene expression. 
The principal aim of the present study was to evaluate gene transfer efficacy to 
vascular lesions using cRGD-PEG-PAsp(DET) micelles and PEG-PAsp(DET) micelles. 
Vascular lesions as the target of gene therapy are generally related to atherosclerosis or 
its associated diseases, and such lesions develop from the intimal layer of the arterial 
wall. Major cell components of intimal lesions are intimal SMC and 
monocytes/macrophages, and previous studies showed that the biological properties of 
these cells were markedly different from those of medial SMC and other cells in normal 
artery.43,44 Thus, to develop gene transfer methods targeting vascular lesions, in vivo 
experiments must be carried out on artery with intimal lesions, not normal artery. In the 
present study, we induced neointimal hyperplasia in the rat carotid artery by balloon 
injury, and then administered polyplex micelles into the same artery, which might be an 
appropriate model to acquire highly reliable data on vascular gene transfer. 
In vivo study using the luciferase gene showed that overall gene expression with 
the polyplex micelles at N/P ratio of 5 was markedly higher than that at N/P ratio of 20, 
and the time-course of gene expression revealed a clear contrast between the delivery 
with cRGD-PEG-PAsp(DET) micelles (N/P = 5) and that with PEG-PAsp(DET) 
micelles (N/P = 5). Namely, delivery with cRGD-PEG-PAsp(DET) micelles facilitated 
sustained gene expression, while that with PEG-PAsp(DET) micelles promoted rapid 
but transient expression of the transferred gene. The contrast in gene expression 
between these micelles could be explained by the difference in intracellular trafficking 
after endocytosis. Since cRGD peptide possesses high affinity with αvβ3, 
cRGD-PEG-PAsp(DET) micelles might be predominantly internalized through 
caveolae-mediated endocytosis, whereby the micelles undergo neither enzymatic 
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degradation nor pH decrease during intracellular trafficking.45 The avoidance of 
enzymatic degradation potentially prolonged the half-life of pDNA in the cells, and then 
realized sustained expression of the transferred gene. The absence of a decrease in pH 
indicated that endosomal membrane destabilization was hardly caused by PAsp(DET) 
polycation of cRGD-PEG-PAsp(DET) micelles, which possibly delayed translocation of 
the gene toward the cytoplasm. The present study indeed showed that gene expression at 
1 day after treatment with cRGD-PEG-PAsp(DET) micelles was considerably lower 
than that with PEG-PAsp(DET) micelles, although in vivo uptake of Cy3-pDNA at 1 
day after treatment with cRGD-PEG-PAsp(DET) micelles was significantly superior to 
that with PEG-PAsp(DET) micelles. In contrast, PEG-PAsp(DET) micelles might be 
mostly internalized via clathrin-mediated endocytosis and then transported to the 
endosomes. A low pH in the endosomes potentially protonated some PEG-PAsp(DET) 
micelles and accelerated translocation of the gene toward the cytoplasm by endosomal 
membrane destabilization, which might promote rapid expression of the transferred 
gene. However, since other PEG-PAsp(DET) micelles were inevitably transported to the 
lysozomes and digested by enzymatic hydrolysis, gene expression might tend to be 
transient. We consider that such a difference in the gene expression pattern suggests the 
possibility of combined application of cRGD-PEG-PAsp(DET) and PEG-PAsp(DET) 
micelles. If both micelles were simultaneously administered to the targeted artery, it 
might be feasible to achieve rapid and sustained gene expression in the arterial wall. 
In conclusion, polyplex micelles with cRGD-PEG-PAsp(DET) achieved 
significantly more efficient gene expression and cellular uptake as compared with 
ligand-free PEG-PAsp(DET) micelles in both HUVEC and VSMC, which expressed 
αvβ3 and αvβ5 integrins. Tracer study of pDNA showed that cRGD-PEG-PAsp(DET) 
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micelles were internalized into HUVEC and VSMC via caveolae-mediated endocytosis, 
and that PEG-PAsp(DET) micelles were internalized via clathrin-mediated endocytosis. 
Further, in vivo evaluation in a rat carotid artery with neointimal hyperplasia revealed 
that cRGD-PEG-PAsp(DET) micelles realized sustained gene expression, while 
PEG-PAsp(DET) micelles facilitated rapid but transient gene expression. These findings 
demonstrated that cRGD-PEG-PAsp(DET) and PEG-PAsp(DET) micelles possessed 
different characters of gene expression in vivo and efficiently functioned as non-viral 
gene vectors for vascular lesions. 
 
 
Materials and Methods 
Synthesis of cRGD-PEG-PAsp(DET) and PEG-PAsp(DET) 
Acetal-PEG-PAsp(DET) was prepared as previously reported. Briefly, 
β-benzyl-L-aspartate N-carboxyanhydride was polymerized in 
N,N-dimethylformamide/CH2Cl2 (1 : 10) at 35˚C by initiation from the primary amino 
group of acetal-PEG-NH2 (Mw of PEG: 12,000 g/mol). Acetal-PEG-b-poly(β-benzyl 
L-aspartate) (acetal-PEG-PBLA) was recovered by precipitation in an excess amount of 
n-hexane/AcoEt (6 : 4), and the filtrate was dried in vacuo. The degree of 
polymerization of PBLA was calculated as 68 from the 1H NMR spectrum (data not 
shown). The side-chain aminolysis reaction of PBLA was then performed by mixing 
with a 50-fold excess of diethylenetriamine (DET) in NMP at 0˚C to obtain 
acetal-PEG-PAsp(DET). Introduction of cRGD peptide (Peptide Institute, Osaka, Japan) 
into block copolymer was carried out as previously reported. Briefly, 
acetal-PEG-PAsp(DET) was added to cRGD peptide in 0.2 M AcOH buffer (pH 4.0) 
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and stirred at room temperature for 5 days. The reacted polymer was purified by dialysis 
with 0.01 N HCl and distilled water and lyophilized to obtain cRGD-PEG-PAsp(DET). 
The introduction rate of the cRGD peptide ligands was determined to be 45% from the 
1H NMR spectrum (data not shown). 
 
Detection of αvβ3 and αvβ5 integrins on HUVEC and VSMC 
HUVEC (Cambrex Corporation, East Rutherford, NJ), cultured in EBM-2 medium 
containing growth supplement (Lonza, Walkersville, MD), and human VSMC (Applied 
Cell Biology Research Institute, Kirkland, WA), cultured in CS-C medium (Applied 
Cell Biology Research Institute), were detached by trypsin treatment, and 5 × 105 cells 
were resuspended in 100 µL EBM-2 medium for HUVEC and CS-C medium for VSMC. 
FITC-labeled antibody against αvβ3 integrin, αvβ5 integrin, or mouse IgG (2 µg, Cosmo 
Bio Co., Ltd., Tokyo, Japan) was added to each cell suspension, followed by incubation 
on ice for 1 h in the dark. The cells were washed three times with cold medium and, 
after being resuspended in PBS, were analyzed by flow cytometry (BD LSR II 
instrument, BD Biosciences, Franklin Lakes, NJ). This experiment was performed 
twice. 
 
Plasmids 
Plasmid pCAccluc+ was constructed by inserting the recombinant luciferase gene 
(luc+) into the pCAGGS expression vector. Plasmids were grown in competent DH5α E. 
coli and purified with a QIAGEN HiSpeed Plasmid MaxKit (Germantown, MD). In 
order to analyze the localization of the transferred gene, pDNA was labeled with Cy5 or 
Cy3 (Label IT kits, Pierce Co., Inc., Rockford, IL). 
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Preparation of polyplex micelles 
cRGD-PEG-PAsp(DET), PEG-PAsp(DET) and pDNA were separately dissolved in 
10 mM Hepes buffer (pH 7.4). The polymer solution was added to a 2-fold excess 
volume of pDNA solution to form polyplex micelles at various N/P ratios, the residual 
molecular ratio of amino groups in the block copolymer to phosphate groups in pDNA. 
 
In vitro gene transfer to HUVEC and VSMC 
HUVEC or VSMC were seeded on 24-well culture plate (20,000 cells / well) and 
cultured overnight in 500 µL EBM-2 or CS-C medium, respectively. pCAccluc+ was 
complexed with cRGD-PEG-PAsp(DET) or PEG-PAsp(DET), and N/P ratios of the 
polyplex micelles were adjusted to 2, 5, 10, 20 and 30 for gene transfer to HUVEC, and 
2, 4, 5, 10 and 20 for gene transfer to VSMC. After replacement with fresh culture 
medium, 30 µL micelle solution (33.3 µg pDNA / mL) was applied to each well (1 µg 
pDNA / well) (n =3) and incubated at 37˚C. At 24 h after application of micelle solution, 
the cells were lysed in 100 µL cell culture lysis reagent (Promega), and luciferase 
activity was evaluated using a Luciferase assay kit (Promega) and a Lumat LB9507 
luminometer (Berthold Technologies, Bad Wildbad, Germany). The results were 
expressed as relative light units (RLU) per milligram of total protein measured using a 
Micro BCA protein assay reagent kit (Rockford). 
 
Cellular uptake of polyplex micelles 
HUVEC or VSMC was seeded on 6-well culture plates (100,000 cells / well) and 
incubated overnight in 2 mL of each medium. Cy5-pDNA was complexed with 
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cRGD-PEG-PAsp(DET) or PEG-PAsp(DET) at N/P ratio of 5, and 90 µL of each 
micelle solution (33.3 µg pDNA / mL) was applied to each well (3 µg pDNA / well) 
after replacement with fresh culture medium and incubated at 37˚C. At 0.5, 1, 3 and 6 h 
after application of micelle solution (n = 4), the medium was removed and the cells 
were washed 3 times with PBS. After detachment by trypsin, the cells were 
re-suspended in PBS and analyzed by flow cytometry. 
 
Intracellular distribution of incorporated pDNA 
HUVEC or VSMC were seeded on a 35-mm glass base dish (100,000 cells / dish, 
Iwaki, Tokyo, Japan) and incubated overnight in 2 mL of each medium. After medium 
change, 90 µL polyplex micelle (containing Cy5-pDNA) solution (N/P = 5, 33.3 µg 
pDNA / mL) was applied to a glass base dish, and incubated for 6 or 24 h (n = 3). The 
intracellular distribution of the polyplex micelles was observed with a confocal laser 
scanning microscope (CLSM) after staining acidic endosomes and lysosomes with 
LysoTracker Green (Molecular Probes, Eugene, OR), or lipid rafts and caveosomes with 
CT-B Alexa Fluor 488 (Molecular Probes). CLSM observation was performed using an 
LSM 510 (Carl Zeiss, Oberlochen, Germany) with a C-Apochromat 63× objective (Carl 
Zeiss) at a suitable excitation wavelength. 
To evaluate the final destination of polyplex micelles, the rate of colocalization of 
Cy5-pDNA with LysoTracker Green or CT-B Alexa Fluor 488 was quantified. 
LysoTracker Green was used as a marker of late endosomes and lysosomes, and CT-B 
Alexa Fluor 488 was used as a marker of lipid rafts and caveosomes. Colocalization was 
quantified as follows: 
Colocalization ratio = Pixcolocalization / Pixtotal 
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where Pixcolocalization represents the number of Cy5 pixels colocalizing with LysoTracker 
Green or CT-B Alexa Fluor 488, and Pixtotal represents the number of all pixels in the 
cell. 
 
Animal model and evaluation of gene expression efficiency 
All animal experiments were approved by the Institutional Animal Care and Use 
Committee and conducted in conformity with institutional guidelines. SD rats (weight, 
300-400 g: Kurea, Tokyo Japan) fed a normal diet were anesthetized by intraperitoneal 
injection of ketamine (75 mg/kg) and xylazine (10 mg/kg). A 2 Fr Fogarty balloon 
catheter (Baxter Healthcare, CA) was introduced through the first branch of the left 
external carotid artery and passed into the left common carotid artery. The balloon was 
inflated at physiological pressure and passed through the common carotid artery three 
times with constant rotation. At 21 days after balloon injury, polyplex micelles were 
administered into the common carotid artery, in which neointimal hyperplasia had been 
induced. pCAccluc+ was complexed with cRGD-PEG-PAsp(DET) or PEG-PAsp(DET) 
at N/P ratio of 5. Then, proximal sites of the common carotid artery and internal carotid 
artery were clamped with a vessel clip, and a PE-10 tube (Clay Adams) was introduced 
into the common carotid artery through the external carotid artery. After flashing with 
Ringer’s solution, 200 µL of each micelle solution (20 mg pDNA / mL) was gently 
infused into the common carotid artery through the tube (4 mg pDNA). The distal 
common carotid artery was then clamped, and the common carotid artery was left for 20 
min. The vessel clips of the carotid artery were then removed, and the arterial 
circulation was restored. Animals were sacrificed at 1, 2, 3 and 4 days after 
administration of micelles (n = 6-8), and the left common carotid artery was excised. 
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After removal of surrounding connective tissue, each sample was homogenized and 
lysed in 300 μl cell culture lysis reagent, and luciferase activity of each lysate was 
measured. Gene transfer efficiency was evaluated as the ratio of luciferase activity to 
the protein content. The results were expressed as RLU / mg protein. 
Additionally, pCAccluc+ was also complexed with cRGD-PEG-PAsp(DET) or 
PEG-PAsp(DET) at N/P ratio of 20, and other groups of rats were treated with micelle 
solutions (N/P = 20) in the same manner. These animals were killed at 2 and 3 days after 
administration (n = 4-5), and luciferase activity was measured. 
 
In vivo uptake of polyplex micelles 
To evaluate in vivo uptake of polyplex micelles in the carotid artery with neointima, 
Cy3-pDNA was complexed with cRGD-PEG-PAsp(DET) or PEG-PAsp(DET) at N/P 
ratio of 5. The rats were subjected to balloon injury, and 21 days later, 200 µL of each 
micelle solution (20 mg pDNA / mL) was administered to the neointima-induced carotid 
artery in the same manner (n = 3). At 1 day after administration, the carotid arteries 
were excised, and frozen sections (4 μm thick) were cut out. Cross sections of the 
arteries were analyzed by means of a fluorescent digital microscope (BZ-8000, Keyence, 
Osaka, Japan) with a suitable filter set. Briefly, the ring-shaped arterial cross section 
was radially divided into five parts, and a fluorescent photomicrograph of each part was 
acquired as digital data. The fluorescence intensity in the neointima was quantified as 
pixel number (Pixneointima), using image analysis software (WinROOF, Mitani 
Corporation, Fukui, Japan). Since the elastic laminae of the medial layer possessed 
weak autonomous fluorescence, the pixel number of the elastic laminae was also 
quantified (Pixeleastic), and the fluorescence intensity of the neointima was standardized 
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as follows: 
Fluorescence intensity index = Pixneointima / Pixeleastic 
The mean fluorescence intensity indexes of five parts were used as the value of each 
cross section. 
 
Statistical analysis 
All values are shown as mean ± S.E.M. Statistical significance was determined by 
two-sided Mann-Whitney’s U test. Differences with P < 0.05 were considered 
significant. 
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Figure legends 
 
Figure 1. (a) Chemical structure of cRGD-PEG-PAsp(DET) block copolymer. (b) 
Schematic illustration of polyplex micelle formation through electrostatic forces. 
 
Figure 2. Flow cytometric analysis of integrin expression on HUVEC (a) and VSMC 
(b). FITC-labeled antibodies against αvβ3 integrin (blue), αvβ5 integrin (red), or mouse 
IgG (black) was added to each cell suspension, followed by incubation on ice in the 
dark. 
 
Figure 3. Effect of luciferase gene expression in vitro. HUVEC (a) and VSMC (b) were 
transfected with cRGD-PEG-PAsp(DET) and PEG-PAsp(DET) micelles prepared at 
various N/P ratios. Gene expression was assessed by measuring luciferase activity 24 
hours later. Data are mean±S.E.M. (* P < 0.05). 
 
Figure 4. Cellular uptake of polyplex micelles (N/P=5). cRGD-PEG-PAsp(DET) 
micelles with N/P ratio of 5 loaded with Cy5-labeled pDNA were applied to HUVEC 
(a) and VSMC (b) for various incubation times. PEG-PAsp(DET) micelles containing 
Cy5-pDNA were used as control. Mean fluorescence intensity at each incubation time 
was assessed. Data are mean±S.E.M. (*P < 0.05, **P < 0.01) 
 
Figure 5. Intracellular distribution of pDNA challenged by polyplex micelles. 
cRGD-PEG-PAsp(DET) and PEG-PAsp(DET) micelles loaded with Cy5-labeled pDNA 
(red) were incubated with HUVEC (a, b) and VSMC (e, f) for 6 and 24 hours. Confocal 
laser scanning observation was performed using a 63× objective. The acidic endosomes 
and lysosomes were stained with LysoTracker Green (green), and the lipid rafts and 
caveosomes were stained with CT-B Alexa Fluor 488 (green). The rate of colocalization 
of Cy5-pDNA with LysoTracker Green or CT-BAlexa Fluor 488 was quantified (c, d, g, 
h). Data are mean ±S.E.M. RGD(-) = PEG-PAsp(DET) micelles. RGD(+) = 
cRGD-PEG-PAsp(DET) micelles. 
 
Figure 6. In vivo gene expression evaluated from luciferase activity after intra-arterial 
delivery of c RGD-PEG-PAsp(DET) and PEG-PAsp(DET) micelles at N/P ratios of 5 
(a) and 20 (b, c). Each polymer was complexed with pCAccluc+ and instilled into rat 
carotid artery with neointima. At 1, 2, 3 and 4 days (a), and at 2 and 3 days (b, c), the 
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common carotid artery was excised and luciferase activity was measured. Values are 
expressed as RLU / mg protein. Values are shown as mean ±S.E.M (*P < 0.05, **P < 
0.01). RGD(-) = PEG-PAsp(DET) micelles. RGD(+) = cRGD-PEG-PAsp(DET) 
micelles. 
 
Figure 7. Photomicrographs of rat carotid artery transfected with polyplex micelles 
composed of Cy3-labeled pCAccluc+ and cRGD-PEG-PAsp(DET) at N/P ratio of 5 (a) 
and composed of Cy3-labeled pCAccluc+ and PEG-PAsp(DET) as control (b). Mean 
fluorescence intensity index in neointima of each section. Values are shown as 
mean±S.E.M (c). Representative photomicrograph of rat carotid artery with 
hematoxylin-eosin staining (d). RGD(-) = PEG-PAsp(DET) micelles. RGD(+) = 
cRGD-PEG-PAsp(DET) micelles. L, lumen; I, intima; M; media; A; adventitia. 
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